Use of Positron Emission Tomography in Anticancer Drug Development

被引：0
|
作者：
Eric O. Aboagye
Patricia M. Price
机构：
[1] Faculty of Medicine,PET Oncology Group, Department of Cancer Medicine, Imperial College of Science, Technology and Medicine
[2] Department of Cancer Medicine,undefined
来源：
Investigational New Drugs | 2003年 / 21卷
关键词：
positron emission tomography; pharmacokinetics; pharmacodynamics; modeling; anticancer; drug development;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Positron emission tomography (PET) is increasingly being used in anticancer drug development. The technique is applicable to studies of drug delivery, and where specific probes are available, to provide pharmacodynamic readouts noninvasively in patients. Mathematical modeling of the imaging data enhances the quality of information that is obtained from such studies. This section provides a review of the PET methodologies that have been used for the development of new cancer therapies. Other than imaging of radiolabeled drugs, PET modeling has found extensive application in studies with 2-[11C]thymidine, [18F]fluorodeoxyglucose, H215O, C15O, and receptor ligands.
引用
下载
收藏
页码：169 / 181
页数：12
相关论文
共 50 条
  • [41] USE OF POSITRON EMISSION TOMOGRAPHY IN NEUROLOGICAL DISEASE
    PATY, DW
    CLINICAL BIOCHEMISTRY, 1985, 18 (03) : 200 - 200
  • [42] THE USE OF POSITRON EMISSION TOMOGRAPHY IN PION RADIOTHERAPY
    GOODMAN, GB
    LAM, GKY
    HARRISON, RW
    BERGSTROM, M
    MARTIN, WR
    PATE, BD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (10): : 1867 - 1871
  • [43] Overview of Positron Emission Tomography, Hybrid Positron Emission Tomography Instrumentation, and Positron Emission Tomography Quantification
    Kwee, Thomas C.
    Torigian, Drew A.
    Alavi, Abass
    JOURNAL OF THORACIC IMAGING, 2013, 28 (01) : 4 - 10
  • [44] USE OF POSITRON EMISSION TOMOGRAPHY FOR STUDY OF LANGUAGE
    RONSON, A
    ACTA NEUROLOGICA BELGICA, 1994, 94 (04): : 231 - 238
  • [45] The use and importance of liposomes in Positron Emission Tomography
    Silindir, Mine
    Ozer, A. Yekta
    Erdogan, Suna
    DRUG DELIVERY, 2012, 19 (01) : 68 - 80
  • [46] Positron emission tomography: A story of radiotracer development
    Reid, Alicia E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [47] Development of a positron emission tomography risks map
    Rodriguez Fernandez, A.
    Trivino Ibanez, E. M.
    Gomez Rio, M.
    Perez Lazaro, J. J.
    Fernandez Ruiz, I
    Ramirez Navarro, A.
    Garcia Rivero, Y.
    Cordoba Canete, E.
    Romero Fernandez, C.
    Llamas-Elvira, J. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2019, 38 (01): : 38 - 45
  • [48] The advantage of using positron emission tomography in drug research
    Farde, L
    TRENDS IN NEUROSCIENCES, 1996, 19 (06) : 211 - 214
  • [49] Positron emission tomography imaging of drug concentrations in the brain
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2021, 23 (04) : 537 - 538
  • [50] Microfluidics for Positron Emission Tomography Probe Development
    Wang, Ming-Wei
    Lin, Wei-Yu
    Liu, Kan
    Masterman-Smith, Michael
    Shen, Clifton Kwang-Fu
    MOLECULAR IMAGING, 2010, 9 (04): : 175 - 191
12345